+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression

Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression

Alimentary Pharmacology & Therapeutics 12(10): 1033-1038

Background: Two studies were carried out in order to investigate the issue of meal-provoked nocturnal gastro-oesophageal reflux. Methods: In Experiment 1, 20 symptomatic reflux patients underwent both pH and polysomnographic monitoring on two nights. On one night, patients ate a non-provocative meal prior to 19.00 hours, while on the other night patients consumed a late evening meal (21.00 hours). In Experiment 2, 17 symptomatic reflux patients were studied using pH and polysomnographic monitoring on two nights subsequent to a late evening provocative meal. On one night, patients received 75 mg of the H2-antagonist ranitidine, while on another night they received a placebo. The data from 12 of the 17 patients studied were used in the analysis. Results: For Experiment 1, no significant differences in the number or duration of reflux events, acid exposure (total %), or polysomnographic measures of per cent of sleep stages between the two nights were observed. The results of the second experiment demonstrated that when given ranitidine, patients experienced significant decrease in acid contact time (total %), and mean duration of reflux events. Subjective reports of discomfort and sleep disturbance were also significantly improved on the drug night. However, significant differences in polysomnographic measures were not observed. Conclusions: Based on these results, we conclude that in some symptomatic reflux patients a late-night non-provocative meal may not increase the incidence of gastro-oesophageal reflux, and that a low dose of an H2-antagonist is effective in decreasing oesophageal acid contact time following a late evening provocative meal.

(PDF emailed within 0-6 h: $19.90)

Accession: 033411401

Download citation: RISBibTeXText

PMID: 9798810

DOI: 10.1046/j.1365-2036.1998.00407.x

Related references

The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Alimentary Pharmacology & Therapeutics 21(2): 103-108, 2005

The impact of intensifying acid suppression on sleep disturbance related to gastro-oesophageal reflux disease in primary care. Alimentary Pharmacology & Therapeutics 37(7): 730-737, 2013

CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: Variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms. Alimentary Pharmacology & Therapeutics 17(12): 1521-1528, 15th June, 2003

Sleep-related breathing disorders in small children with nocturnal acid gastro-oesophageal reflux. Roczniki Akademii Medycznej W Bialymstoku 49(): 98-102, 2005

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 33(1): 118-124, 1992

Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Alimentary Pharmacology & Therapeutics 18(9): 883-890, 2003

Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: Lansoprazole vs. pantoprazole. Alimentary Pharmacology & Therapeutics 17(2): 235-241, January, 2003

Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole. Digestive and Liver Disease 38(2): 85-90, 2005

Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Alimentary Pharmacology & Therapeutics 26(1): 41-48, 2007

Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy. Gut 63(5): 720-726, 2014

Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care. Alimentary Pharmacology & Therapeutics 15(6): 765-772, 2001